Cutaneous involvement in Hodgkin's lymphoma: report of two cases.
Hodgkin's lymphoma (HL) comprises 20 to 30% of all lymphomas. Skin involvement is almost always secondary to visceral or nodal involvement. Secondary cutaneous HL is rare, occurring in only 0.5 to 3.4% of the cases. Herein we report two cases of skin involvement in Hodgkin's disease. One was a 25-year-old female admitted with a draining sinus in the neck. The other was a 19-year-old female admitted with a neck mass and skin papules on her chest and arm. Skin involvement may antecede or can be seen during the course of HL. Better understanding of such cutaneous involvement, which occasionally may be the initial sign of HL, is needed, and a biopsy of any suspicious skin lesion should be considered.
Erkiliç
Suna
S
Department of Pathology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
Erbagci
Zulal
Z
Koçer
N Emrah
NE
Bayazit
Yildirim A
YA
Camci
Celalettin
C
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D015251:Epirubicin; D014747:Vinblastine; D003606:Dacarbazine